Showing results (1281-1290 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|March 4, 2026
Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA studyPeter C Taylor, Georg Schett, Tom W J Huizinga, et al.
RMD Open|March 4, 2026
Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort studyMyrto Nikoloudaki, Georgios D Barmparis, Sofia Pitsigavdaki, et al.
RMD Open|October 19, 2016
Cardiac involvement in adult and juvenile idiopathic inflammatory myopathiesThomas Schwartz, Louise Pyndt Diederichsen, Ingrid E Lundberg, et al.
RMD Open|October 19, 2016
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trialVibeke Strand, Eun Bong Lee, Roy Fleischmann, et al.
RMD Open|October 19, 2016
Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entitiesLaura C Cappelli, Ami A Shah, Clifton O Bingham
RMD Open|November 8, 2018
Relapsing polychondritis: state of the art on clinical practice guidelinesSimona Rednic, Laura Damian, Rosaria Talarico, et al.
RMD Open|March 23, 2017
Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitorsVibeke Strand, Matthew Reaney, Chieh-I Chen, et al.
RMD Open|March 20, 2019
Distinct interferon signatures stratify inflammatory and dysimmune myopathiesMuriel Rigolet, Cyrielle Hou, Yasmine Baba Amer, et al.
RMD Open|March 20, 2019
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosisAlarico Ariani, Mario Silva, Elena Bravi, et al.
RMD Open|March 20, 2019
Percentage of progressors in imaging: can we ignore regressors?Alexandre Sepriano, Sofia Ramiro, Robert Landewé, et al.
Pageof 197